These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 41730)

  • 21. Cardiovascular effects of bromocriptine and lergotrile in renal and spontaneously hypertensive rats.
    Tadepalli AS; Novak PJ
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):93-105. PubMed ID: 6141774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the effects of CB-154 and lergotrile mesylate on prolactin and growth hormone secretion in mice.
    Sinha YN; Salocks CB; VanderLaan WP
    Horm Metab Res; 1976 Sep; 8(5):332-6. PubMed ID: 989755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential enhancement of locomotor activity by dopamine agonists following chronic morphine treatment.
    Tye NC; Horsman L; Wright FC; Pullar IA
    Psychopharmacology (Berl); 1979 May; 63(3):313-5. PubMed ID: 39310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of the dopamine agonist, lergotrile mesylate, on prolactin secretion in women.
    Leebaw W; Lee L; Woolf P
    Acta Endocrinol (Copenh); 1978 Jan; 87(1):12-8. PubMed ID: 579527
    [No Abstract]   [Full Text] [Related]  

  • 25. Dopamine receptor-mediated depression of spinal monosynaptic transmission.
    Carp JS; Anderson RJ
    Brain Res; 1982 Jun; 242(2):247-54. PubMed ID: 6126249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of L-dopa and lergotrile mesylate on the interaction of fluphenazine decanoate and amphetamine-induced stereotypy and mortality.
    Lemberger L; Kellams JJ; Small JG; Rowe H
    Commun Psychopharmacol; 1977; 1(5):501-7. PubMed ID: 564259
    [No Abstract]   [Full Text] [Related]  

  • 27. Differentiation of the central dopaminergic stimulants apomorphine and lergotrile.
    Wade RL; Krewsun I; Quock RM
    Proc West Pharmacol Soc; 1979; 22():141-2. PubMed ID: 42079
    [No Abstract]   [Full Text] [Related]  

  • 28. Selective activation by LY-141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and influence of stimulation parameters in the action of dopamine.
    Lokhandwala MF; Steenberg ML
    J Pharmacol Exp Ther; 1984 Jan; 228(1):161-7. PubMed ID: 6694099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lergotrile in the treatment of parkinsonism.
    Klawans HL; Goetz CG; Volkman P; Nausieda PA; Weiner WJ
    Neurology; 1978 Jul; 28(7):699-702. PubMed ID: 566868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
    Schwarcz R; Fuxe K; Agnati LF; Hökfelt T; Coyle JT
    Brain Res; 1979 Jul; 170(3):485-95. PubMed ID: 37986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
    Teychenne PF; Rosin AJ; Plotkin CN; Calne DB
    Br J Clin Pharmacol; 1980 Jan; 9(1):47-50. PubMed ID: 6101955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of catecholamines and adrenergic antagonists on blood glucose, free fatty acids and liver glycogen levels in fed rats.
    Bugajski J; Hano J; Zdebska A
    Pol J Pharmacol Pharm; 1978; 30(6):799-818. PubMed ID: 755244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary and adrenal function in normal women after treatment with Lergotrile mesylate.
    Rabinowitz D; McKenna TJ; Benveniste R
    Isr J Med Sci; 1978 Feb; 14(2):256-60. PubMed ID: 418023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of lergotrile or apomorphine induced turning behavior by haloperidol and clozapine.
    Nakamura S; Engel J; Goldstein M
    Commun Psychopharmacol; 1978; 2(3):185-90. PubMed ID: 29742
    [No Abstract]   [Full Text] [Related]  

  • 35. Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration.
    Kelland MD; Freeman AS; Chiodo LA
    Synapse; 1989; 3(1):30-7. PubMed ID: 2919369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
    Gundlach AL; Krstich M; Beart PM
    Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for an inhibitory dopaminergic and stimulatory noradrenergic hypothalamic influence on PMS-induced ovulation in the immature rat. II. A pharmacological analysis.
    Löfström A; Agnati LF; Fuxe K; Hökfelt T
    Neuroendocrinology; 1977; 24(5-6):289-316. PubMed ID: 347324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Parkinson's disease with lergotrile mesylate.
    Lieberman A; Estey E; Kupersmith M; Gopinathan G; Goldstein M
    JAMA; 1977 Nov; 238(22):2380-2. PubMed ID: 335094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STUDIES ON THE HYPERGLYCAEMIA INDUCED BY CHLORPROMAZINE IN RATS.
    BONACCORSI A; GARATTINI S; JORI A
    Br J Pharmacol Chemother; 1964 Aug; 23(1):93-100. PubMed ID: 14208196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.